Bought for a million dollars and milestone based payments. The ovarian study is pre-clinical. Long way to go to complete phae 1-3 and then get to market. However, huge interest in AUS. Can any one explain what is going on. I am a long time holder and got MEIP distribution and sold NVGN yesterday., Still kicking myself. Congratulations to the old timers who are still there.
I am baffled by the interest in Australia. Anyone has any insight.
Indeed a mystery, There is something unusual about the share turnover for the past several days. The news release does not warrant the interest or the rise. The study is pre-clinical and way too early. It seems like a coordinated action. Is there an ATM in place for NVGN shares? They could have raised some serious money.